
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny Inc. is experiencing significant growth in its fertility services, evidenced by a 39% year-over-year increase in egg retrievals and bankings, reflecting heightened demand particularly among women in the tech sector. The company anticipates substantial revenue opportunities through the launch of its fully-insured product offering, which is expected to align with increasing state mandates for IVF, thus expanding its market potential. Furthermore, Progyny has achieved near 100% client retention, with a notable 30% of clients opting to enhance their benefits, while the number of covered lives with access to additional services is projected to grow from 1.5 million in 2025 to 2.7 million in 2026, underlining a strong expansion trajectory.
Bears say
Progyny Inc faces fundamental challenges that contribute to a negative outlook on its stock due to economic uncertainty and competitive pressures in the fertility benefits market. The company has experienced a reduction in expected covered lives, decreasing from approximately 7.6 million to 7.2 million, coupled with a decline in guidance of adjusted EBITDA estimates to a range of $224 to $239 million, below previous expectations. Additionally, the potential impact of consumers hesitating to utilize expensive fertility benefits amid rising unemployment and a competitive market landscape raises concerns about Progyny's future revenue growth and overall financial stability.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares